Breast cancer Posts on Medivizor
Navigation Menu

Breast cancer Posts on Medivizor

Adding everolimus to endocrine therapy in patients with HER2- ER+ advanced breast cancer

Posted by on Jan 5, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if treating breast cancer with everolimus (Afintor) and endocrine therapy is better than only treating with endocrine therapy. The study found that using everolimus in addition to endocrine therapy had a significant benefit to survival in these patients. Some background Breast cancer is classified into types...

Read More

Length of treatment with trastuzumab in HER2+ early stage breast cancer

Posted by on Jan 2, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out what the best length of treatment with trastuzumab (Herceptin) is for HER2+ early stage breast cancer. The study found that at least one year of treatment had the best results in terms of how well it worked, and the cost-effectiveness. Some background HER-2 positive breast cancer is a type of cancer where...

Read More

Treating BRCA1/2 mutated breast cancer that has spread with lurbinectedin

Posted by on Dec 27, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out how well lurbinectedin (PM01183) works in treatment of breast cancer with BRCA1/2 mutations (abnormal genes), which has spread. The study found that lurbinectedin worked well in treating patients with BRCA1/2 mutated breast cancer which had spread. Some background BRCA1 and BRCA2 are genes that stop tumors...

Read More

Treating BRCA1/2 mutated breast cancer that has spread with lurbinectedin

Posted by on Dec 27, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out how well lurbinectedin (PM01183) works in treatment of breast cancer with BRCA1/2 mutations (abnormal genes), which has spread. The study found that lurbinectedin worked well in treating patients with BRCA1/2 mutated breast cancer which had spread. Some background BRCA1 and BRCA2 are genes that stop tumors...

Read More

Adding ixabepilone to capecitabine treatment for triple negative breast cancer.

Posted by on Dec 11, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if ixabepilone (Ixempra) and capecitabine (Xeloda) work for treating triple-negative breast cancer in patients with hard to treat disease compared to using capecitabine alone. The study found that adding ixabepilone to treatment resulted in longer survival without the cancer progressing. Some background...

Read More

Joint pain management in obese breast cancer patients treated with aromatase inhibitors

Posted by on Dec 8, 2018 in Breast cancer | 0 comments

In a nutshell This article investigated the safety and effectiveness of adding Omega-3 fatty acid (O3-FA) to the management of joint pain in patients with breast cancer treated with aromatase inhibitors. The authors concluded that the addition of O3-FA is safe and gave the greatest benefit to patients who were obese.  Some background...

Read More

Adding pertuzumab to treatment in breast cancer

Posted by on Dec 4, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out which treatment is better for breast cancer, chemotherapy plus trastuzumab (Herceptin) and surgery, or pertuzumab (Perjeta), and chemotherapy plus trastuzumab (Herceptin) and surgery. The study found that adding pertuzumab to the standard treatment worked better to completely remove all signs of cancer compared...

Read More